Protherapies Digest PRO
Natural health product licensed in Canada
- Other names
- Digest PRO
- Licence holder
- Neutrical Solutions Inc.
- NPN or DIN-HM
- 80075882
- Status
- Active licence
- Licence date
- 28 February 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Glutamine Source : L-Glutamine | 100 milligramme | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 12,633 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 15.79 milligramme | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 53.33 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1.33 milligramme | Not calculated |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Chlorhydrate de bétaine | 150 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 2.78 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 500 FCC CU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5,000 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 33.33 milligramme | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 4,737 Unité de pepsine du FCC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 4.74 milligramme | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 0.5 milligramme | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 100 FCC SU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 150 FCC DP | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 16.67 milligramme | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 1.67 milligramme | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 50 FCC GalU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 300 FCC ALU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 3 milligramme | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 19.48 milligramme | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 5,356 FCC HUT | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, NA, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Digestive Aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur, in which, discontinue use. Hypersensitivity/allergy has been known to occur, in which case discontinue use.
- Précautions et mises en garde
Consult a health care practitioner if symptoms of digestive distress persist or worsen. Consult a health care practitioner if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticolagulant agents, anti-inflammatory agents or other enzyme products or are having surgery. Consult a health care practitioner prio to use if you have diabetes or galactosemia. Hypersensitivity/allergy has been known to occur, in which case discontinue use. Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur, in which, discontinue use. Consult a health care practitioner prior to use if you have cardiovascular disease.
Source
Official Health Canada record, licence 80075882
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.